ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.

[ACCESSWIRE @accesswire]

As companies face the task of determining how to best bring some employees back to the workplace, here are five PR strategies to keep in mind when communicating. https://t.co/EyZyIRfgot

#WorkFromHome #WFH #PublicRelations

[ACCESSWIRE @accesswire]

🎀 We’re proud to lace up our sneakers and join the Susan G. Komen Walk in Nashville! At ACCESSWIRE, giving back is in our DNA. Together, we’re stronger! #BreastCancerAwareness #WalkForACure #ACCESSWIRECares #StrongerTogether 🎗️

[ACCESSWIRE @accesswire]

👀 Want to know how data can elevate your PR game and prove your ROI? Dive in and discover how modern PR is creating real business impact.

Read the Blog Now!
https://t.co/2DQ2uRc91Z

#PRTrends #DataDrivenPR #PublicRelations #MediaMonitoring #PRInsights #DigitalPR

[ACCESSWIRE @accesswire]

Exciting insights from our New Healthcare Trend Report are now here!
Download your report today! https://t.co/QO6jJX1mah
What are your thoughts on these trends? Share with us using #healthcaretrends #healthcarepr #pharmainnovation #PublicRelations

[ACCESSWIRE @accesswire]

Aytu BioPharma (@AytuBioPharma_) to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024
https://t.co/gjD6rQBxI7

[ACCESSWIRE @accesswire]

Petros Pharmaceuticals (@PetrosPharma) Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
https://t.co/dNzfIdGlCo

[ACCESSWIRE @accesswire]

Envela (@EnvelaCorp) to Participate at the Lake Street Best Ideas Growth Conference
https://t.co/IIrbfSWd4T

[ACCESSWIRE @accesswire]

AYRO (@AyroInc) Appoints New Management Team to Re-Engineer and Revamp a Lower Cost Low-Speed Electric Vehicle
https://t.co/idSRdu7RNi

[ACCESSWIRE @accesswire]

Full Alliance Group, Inc. (@OTCFAGI) (OTC: FAGI) Wholly Owned Subsidiary Dynamaxx Health Inc. Secures Its Own Manufacturing Contract for Medical Devices for MAXX Health Clinics
https://t.co/9ygNKSeig3

[ACCESSWIRE @accesswire]

Aytu BioPharma (@AytuBioPharma_) to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
https://t.co/4JjLd4DxCN

[ACCESSWIRE @accesswire]

FSD Pharma (@FsdPharma) Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team
https://t.co/2G5v8hk0yd

[ACCESSWIRE @accesswire]

Idaho Strategic (@IdahoStrategic) Receives Grant Funding to Support Power Infrastructure Upgrades to the Golden Chest Mine
https://t.co/v4h61YeCdf

[ACCESSWIRE @accesswire]

Envela (@EnvelaCorp) Reports Second Quarter 2024 Financial Results
https://t.co/ABFNbncRTa

[ACCESSWIRE @accesswire]

Aytu BioPharma (@AytuBioPharma_) Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
https://t.co/9f09ZxZXLm

[ACCESSWIRE @accesswire]

Envela (@EnvelaCorp) to Announce Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
https://t.co/bM6FbXVCJI

[ACCESSWIRE @accesswire]

Petros Pharmaceuticals' (@PetrosPharma) Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
https://t.co/wJdvJwboVc

[ACCESSWIRE @accesswire]

Paragon Technologies Recommends Ocean Power Shareholders Vote AGAINST the Company's Plan to Increase Its Authorized Shares and Hold the Board Accountable for Its Wasteful Spending That Leads to Increasing Losses
https://t.co/093I7hEy5S

[ACCESSWIRE @accesswire]

IotaComm (@iotacomm) Announces Appointment of New Board Member and Key Corporate Actions
https://t.co/POJ84g9NhR

[ACCESSWIRE @accesswire]

Idaho Strategic (@IdahoStrategic) to Present at the MicroCap Leadership Summit and Provide Attendees with a Tour of the Golden Chest Mine
https://t.co/ZjqhOEEtXb

[ACCESSWIRE @accesswire]

Petros Pharmaceuticals’ (@PetrosPharma) STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
https://t.co/Ytz3SemFky

[ACCESSWIRE @accesswire]

FSD Pharma (@FsdPharma) Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
https://t.co/vD5coLeAxg